UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2170) 2170
animals (2120) 2120
humans (2063) 2063
life sciences & biomedicine (2062) 2062
male (1895) 1895
cardiomegaly - drug therapy (1429) 1429
rats (1225) 1225
cardiovascular system & cardiology (954) 954
cardiomegaly - physiopathology (947) 947
female (937) 937
cardiomegaly - etiology (882) 882
biological and medical sciences (802) 802
hypertension - drug therapy (796) 796
cardiomegaly - pathology (767) 767
medical sciences (752) 752
cardiac & cardiovascular systems (741) 741
cardiomegaly - metabolism (686) 686
middle aged (652) 652
heart (590) 590
abridged index medicus (542) 542
hypertension - complications (536) 536
adult (535) 535
hypertrophy (535) 535
blood pressure - drug effects (529) 529
mice (502) 502
cardiomegaly - prevention & control (489) 489
myocardium - pathology (475) 475
cardiovascular system (466) 466
cardiac hypertrophy (452) 452
heart failure (452) 452
pharmacology & pharmacy (436) 436
myocardium - metabolism (426) 426
disease models, animal (418) 418
echocardiography (418) 418
hypertension (413) 413
pharmacology. drug treatments (396) 396
hypertension - physiopathology (391) 391
peripheral vascular disease (390) 390
cardiomegaly - complications (379) 379
rats, sprague-dawley (379) 379
antihypertensive agents - therapeutic use (340) 340
aged (339) 339
electrocardiography (332) 332
heart failure - drug therapy (320) 320
heart enlargement (313) 313
myocytes, cardiac - drug effects (313) 313
cardiology. vascular system (300) 300
myocytes, cardiac - metabolism (299) 299
cardiomegaly - chemically induced (296) 296
fibrosis (288) 288
heart - drug effects (288) 288
cardiomegaly - genetics (284) 284
cell biology (284) 284
physiology (275) 275
time factors (270) 270
blood pressure (263) 263
rats, inbred shr (258) 258
rats, wistar (250) 250
rodents (243) 243
cardiomegaly - diagnostic imaging (242) 242
mice, inbred c57bl (238) 238
heart failure - physiopathology (230) 230
myocytes, cardiac - pathology (230) 230
antihypertensive agents (219) 219
signal transduction (218) 218
hemodynamics - drug effects (217) 217
cells, cultured (213) 213
heart diseases (203) 203
signal transduction - drug effects (193) 193
gene expression (192) 192
angiotensin-converting enzyme inhibitors - therapeutic use (188) 188
risk factors (187) 187
medicine, research & experimental (171) 171
physiological aspects (171) 171
research & experimental medicine (171) 171
cardiomegaly - enzymology (170) 170
myocardial infarction - drug therapy (165) 165
cardiology (161) 161
heart rate - drug effects (161) 161
myocardial contraction - drug effects (161) 161
cardiomegaly - diagnosis (159) 159
cardiomyocytes (158) 158
heart - physiopathology (158) 158
biochemistry & molecular biology (157) 157
heart failure - etiology (157) 157
cardiomegaly (155) 155
cardiovascular (154) 154
ventricular remodeling - drug effects (152) 152
health aspects (147) 147
research (146) 146
apoptosis (144) 144
hemodynamics (144) 144
proteins (144) 144
rats, inbred wky (144) 144
analysis (136) 136
angiotensin ii (136) 136
blood and lymphatic vessels (136) 136
angiotensin (135) 135
oxidative stress (133) 133
organ size - drug effects (132) 132
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3262) 3262
German (107) 107
Japanese (74) 74
French (70) 70
Russian (62) 62
Italian (37) 37
Spanish (32) 32
Chinese (20) 20
Portuguese (15) 15
Polish (9) 9
Czech (8) 8
Romanian (4) 4
Bulgarian (2) 2
Danish (2) 2
Norwegian (2) 2
Croatian (1) 1
Dutch (1) 1
Georgian (1) 1
Hebrew (1) 1
Hungarian (1) 1
Slovak (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of molecular and cellular cardiology, ISSN 0022-2828, 2015, Volume 84, pp. 24 - 35
Cardiovascular | Myocardial infarction | Splenic remodeling | Resolution of inflammation | Metabololipidomics | Resolvin D1 | Neutrophils | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cell Biology | Cell Count | Male | Myocardial Infarction - diagnostic imaging | Spleen - drug effects | Extracellular Matrix - genetics | Inflammation - complications | Pulmonary Edema - physiopathology | Inflammation - drug therapy | Pulmonary Edema - complications | Receptors, Formyl Peptide - metabolism | Ultrasonography | Myocardial Infarction - physiopathology | Cell Polarity - drug effects | Spleen - pathology | Neutrophil Infiltration - drug effects | Ventricular Function - drug effects | Docosahexaenoic Acids - therapeutic use | Arachidonate 5-Lipoxygenase - metabolism | Docosahexaenoic Acids - chemistry | Extracellular Matrix - drug effects | Mice, Inbred C57BL | Cardiomegaly - diagnostic imaging | Cardiomegaly - drug therapy | Cardiomegaly - physiopathology | Pulmonary Edema - drug therapy | Cardiomegaly - complications | Collagen - metabolism | Docosahexaenoic Acids - pharmacology | Myocardial Infarction - complications | Macrophages - metabolism | Animals | Myocardial Infarction - drug therapy | Heart Ventricles - physiopathology | Prostaglandin-Endoperoxide Synthases - metabolism | Macrophages - drug effects | Ventricular Remodeling - drug effects | Heart Ventricles - drug effects | Inflammation | Heart attack | Index Medicus | metabololipidomics | liposomes | myocardial infarction | splenic remodeling | neutrophils | resolution of inflammation
Journal Article
Scientific reports, ISSN 2045-2322, 2015, Volume 5, Issue 1, pp. 8794 - 8794
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Receptors, Angiotensin - metabolism | Diabetic Cardiomyopathies - metabolism | Diabetic Cardiomyopathies - drug therapy | Apoptosis - drug effects | Transforming Growth Factor beta1 - metabolism | Cardiomegaly - etiology | Cardiomegaly - pathology | Male | Peptide Fragments - pharmacology | Perindopril - administration & dosage | Perindopril - pharmacology | Heart Ventricles - ultrastructure | Peptidyl-Dipeptidase A - metabolism | Angiotensin I - pharmacology | Collagen - biosynthesis | p38 Mitogen-Activated Protein Kinases - metabolism | Phosphorylation - drug effects | Drug Therapy, Combination | Heart Ventricles - pathology | Disease Models, Animal | Fibroblasts - metabolism | Echocardiography | Peptide Fragments - administration & dosage | Angiotensin I - administration & dosage | Cardiomegaly - drug therapy | Rats | Diabetic Cardiomyopathies - diagnosis | Ventricular Dysfunction, Left - prevention & control | Blood Glucose - drug effects | Animals | Ventricular Dysfunction, Left - drug therapy | Mitogen-Activated Protein Kinase 3 - metabolism | Cell Differentiation - drug effects | Fibroblasts - drug effects | Cell Communication - drug effects | Fibrosis | Cell Proliferation - drug effects | Fibroblasts - cytology | Hemodynamics - drug effects | Oxidative Stress - drug effects | Heart Ventricles - drug effects | Mitogen-Activated Protein Kinase 1 - metabolism | Heart | Enzymes | Cardiomyopathy | Diabetes mellitus | Rodents | Angiotensin | Diabetes | Ventricle | Angiotensin II | Hypertrophy | Apoptosis | Index Medicus
Journal Article
Blood pressure, ISSN 0803-7051, 2010, Volume 19, Issue 3, pp. 169 - 175
left atrial size | hypertension | prognosis | Atrial fibrillation | Hypertension | Prognosis | Left atrial size | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Antihypertensive Agents - pharmacology | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Hypertension - drug therapy | Male | Risk | Cardiovascular Diseases - complications | Electrocardiography | Female | Blood Pressure - drug effects | Heart Atria - physiopathology | Hypertrophy, Left Ventricular - drug therapy | Atenolol - pharmacology | Heart Rate | Atrial Fibrillation - drug therapy | Cardiomegaly - drug therapy | Losartan - pharmacology | Antihypertensive Agents - therapeutic use | Cardiomegaly - complications | Hypertension - physiopathology | Arrhythmias, Cardiac - drug therapy | Atenolol - therapeutic use | Atrial Fibrillation - epidemiology | Heart Ventricles - physiopathology | Hypertrophy, Left Ventricular - complications | Losartan - therapeutic use | Hypertension - complications | Aged | Arrhythmias, Cardiac - complications | Hypertrophy, Left Ventricular - physiopathology | Atrial Fibrillation - prevention & control | Index Medicus | Heart Atria/physiopathology | Cardiac/complications/drug therapy | Hypertension/complications/drug therapy/physiopathology | Losartan/pharmacology/therapeutic use | Heart Ventricles/physiopathology | Cardiomegaly/complications/drug therapy | Cardiovascular Diseases/complications/drug therapy | Atenolol/pharmacology/therapeutic use | Kardiologi | Cardiac and Cardiovascular Systems | Blood Pressure/drug effects | Atrial Fibrillation/drug therapy/epidemiology/prevention & control | Antihypertensive Agents/pharmacology/therapeutic use | Left Ventricular/complications/drug therapy/physiopathology | Arrhythmias | Hypertrophy
Journal Article
Journal Article
American journal of hypertension, ISSN 0895-7061, 12/2015, Volume 28, Issue 12, pp. 1409 - 1417
Journal Article